Treatment with GLP-1 in normal, insulin-resistant and type-2 diabetic (T2DM) rats, restored the impaired trabecular structure, and while osteocalcin and osteoprotegerin increased in all three groups, RANKL only increased in the T2DM rats (41). Here, GLP1R is linked to type 2 diabetes mellitus.